Proteomic analysis of rat brain mitochondria following exposure to dopamine quinone: implications for Parkinson disease.
about
Transgenic overexpression of mitofilin attenuates diabetes mellitus-associated cardiac and mitochondria dysfunctionChanges in endoplasmic reticulum stress proteins and aldolase A in cells exposed to dopamineHeat shock proteins: cellular and molecular mechanisms in the central nervous system.Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications.Mitochondrial localization of PARP-1 requires interaction with mitofilin and is involved in the maintenance of mitochondrial DNA integrityDopamine quinone modifies and decreases the abundance of the mitochondrial selenoprotein glutathione peroxidase 4.Tolcapone induces oxidative stress leading to apoptosis and inhibition of tumor growth in Neuroblastoma.Neuroproteomics approaches to decipher neuronal regeneration and degeneration.Profiling the mitochondrial proteome of Leber's Hereditary Optic Neuropathy (LHON) in Thailand: down-regulation of bioenergetics and mitochondrial protein quality control pathways in fibroblasts with the 11778G>A mutationHuman SOD2 modification by dopamine quinones affects enzymatic activity by promoting its aggregation: possible implications for Parkinson's diseaseMitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism.Proteomics in animal models of Alzheimer's and Parkinson's diseases.Clinical implications from proteomic studies in neurodegenerative diseases: lessons from mitochondrial proteins.Inhibition of oxidative stress by coenzyme Q10 increases mitochondrial mass and improves bioenergetic function in optic nerve head astrocytes.Proteomic identification of dopamine-conjugated proteins from isolated rat brain mitochondria and SH-SY5Y cells.Mic60/mitofilin overexpression alters mitochondrial dynamics and attenuates vulnerability of dopaminergic cells to dopamine and rotenone.Toxicoproteomics: new paradigms in toxicology research.Mitochondrial proteomics as a selective tool for unraveling Parkinson's disease pathogenesis.Understanding the molecular basis of Parkinson's disease, identification of biomarkers and routes to therapy.Exploiting the potential of molecular profiling in Parkinson's disease: current practice and future probabilities.Protective role of heat shock proteins in Parkinson's disease.Proteostasis and movement disorders: Parkinson's disease and amyotrophic lateral sclerosis.Protective and toxic roles of dopamine in Parkinson's disease.Mass spectrometry and redox proteomics: applications in disease.Mortalin, apoptosis, and neurodegeneration.Tumor Necrosis Factor-Associated Protein 1 (TRAP1) is Released from the Mitochondria Following 6-hydroxydopamine Treatment.Proteomic studies associated with Parkinson's disease.Living on the edge with too many mouths to feed: why dopamine neurons die.Quinone and oxyradical scavenging properties of N-acetylcysteine prevent dopamine mediated inhibition of Na+, K+-ATPase and mitochondrial electron transport chain activity in rat brain: implications in the neuroprotective therapy of Parkinson's diseNuclear translocation of anamorsin during drug-induced dopaminergic neurodegeneration in culture and in rat brain.Protein "amyloid-like" networks at the phospholipid membrane formed by 4-hydroxy-2-nonenal-modified mitochondrial creatine kinase.Covalent adduction of endogenous and food-derived quinones to a protein: its biological significance.Mitochondrial protein sulfenation during aging in the rat brain.
P2860
Q28386173-D4C0F87B-4CA7-4998-A210-C7154A7183EBQ28583030-BBAAE023-3EA8-462D-B539-84F3E82F5299Q30392284-D94C4C3D-CECE-41EC-8273-1E49C0D03080Q30446460-4267D470-CD63-4AC2-8AAF-14EEBB7707F8Q33504492-2900DE7E-D87A-456B-BC73-1CC06C046A29Q33705939-C3BB4498-84F0-41C0-B8CB-5509CE6706FEQ33775239-1864D5CC-932F-4BB0-B183-6BE19240247AQ33855014-4A9A5E52-CF61-4966-8F1D-3B03B70EFF92Q34172317-7B161236-F363-4C87-8AD8-7E191BAF3436Q34313803-38138622-4DC7-4E99-80EE-AC781D557005Q36590693-3A3D3621-B64D-43FB-AFEA-BCAAD2A09AD0Q37071539-9F36FC0E-F7E5-4B3D-BE23-90B3B90D84AAQ37105161-5A4CF581-F2A9-4335-BE41-ECA1C5B07287Q37299591-7D337311-A1C3-47BC-9423-1CC5F36C4139Q37381903-30AD4862-02AB-46E3-9BE2-B1A7B1DFD7D7Q37631968-95070F15-D396-4AFC-AA6B-FF4FEECB2A22Q37696489-97B90568-F943-4991-A5E0-A8DD94BB0799Q37727186-B38B7854-048C-49FA-B280-45BDEAE85F5DQ37775037-1C273E46-B9F1-4713-AAB5-0C31060678A4Q37809870-7FE41ECE-886C-412C-9C52-69953CC9922DQ37826616-892C5C3B-55B6-47F1-BA0E-CD8B82CECAC6Q37918059-8824562F-8CB8-4E02-9CB8-CDD082E4DCE3Q38189127-44A44B2C-2649-4675-B795-8B1A95DFFFC0Q38220377-EB0C12E7-B81A-4D98-9E77-1F53AF21171EQ38223671-52C33477-987C-4A9B-8D96-F89B542AD3F3Q38725685-1BFA67D4-30EE-45EB-A26D-38282F46A06BQ38761409-7BE5E8D8-6155-42FF-8E14-1CC751592548Q41732813-87ACD336-3171-4B6F-B40B-8D8A7B24013FQ46527836-F1D2EF9D-4FEB-4C80-A309-ABF532734BCEQ53455700-AF8E42C7-3933-46C8-A7D2-38B9A4DCA75BQ54278545-CB355B04-E891-481E-BBA2-4AC5CD39A66DQ55294243-63B72BDE-130F-46B1-ADB2-A449FE2C759DQ55403521-B73633B9-3FC6-47D7-854D-61F4952260D0
P2860
Proteomic analysis of rat brain mitochondria following exposure to dopamine quinone: implications for Parkinson disease.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Proteomic analysis of rat brai ...... cations for Parkinson disease.
@en
Proteomic analysis of rat brai ...... cations for Parkinson disease.
@nl
type
label
Proteomic analysis of rat brai ...... cations for Parkinson disease.
@en
Proteomic analysis of rat brai ...... cations for Parkinson disease.
@nl
prefLabel
Proteomic analysis of rat brai ...... cations for Parkinson disease.
@en
Proteomic analysis of rat brai ...... cations for Parkinson disease.
@nl
P2093
P2860
P921
P1476
Proteomic analysis of rat brai ...... ications for Parkinson disease
@en
P2093
Michael Cascio
Teresa G Hastings
Victor S Van Laar
P2860
P304
P356
10.1016/J.NBD.2007.11.007
P577
2007-11-28T00:00:00Z